This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Bernasconi A., Cendes F., Theodore W.H., Gill R.S., Koepp M. J., Hogan R.E. et al.:Recommendations for using structural magnetic resonance imaging in the care of patients with epilepsy: A consensus report from the International League Against Epilepsy Neuroimaging Task Force. Epilepsia, 2019, 60: 1054–1068. doi: 10.1111/epi.15612BernasconiA.CendesF.TheodoreW.H.GillR.S.KoeppM. J.HoganR.E.: Recommendations for using structural magnetic resonance imaging in the care of patients with epilepsy: A consensus report from the International League Against Epilepsy Neuroimaging Task Force. Epilepsia, 2019, 60: 1054–1068. doi: 10.1111/epi.15612Open DOISearch in Google Scholar
de Bruijn M.A.A.M., Bastiaansen A.E.M., Mojzisova H., van Sonderen A., Thijs R.D., Majoie M.J.M. et al.:Antibodies Contributing to Focal Epilepsy Signs and Symptoms Score. Ann Neurol, 2021, 89: 698–710. Doi: 10.1002/ana.26013de BruijnM.A.A.M.BastiaansenA.E.M.MojzisovaH.van SonderenA.ThijsR.D.MajoieM.J.M.: Antibodies Contributing to Focal Epilepsy Signs and Symptoms Score. Ann Neurol, 2021, 89: 698–710. Doi: 10.1002/ana.26013Open DOISearch in Google Scholar
Cabezudo-García P., Ciano-Petersen N.L., Mena-Vázquez N., Ortega-Pinazo J., Postigo-Pozo M.J., García-Martín G. et al.:Prevalence of Neural Autoantibodies in Paired Serum and Cerebrospinal Fluid in Adult Patients with -Resistant Temporal Lobe Epilepsy of Unknown Etiology. J. Clin. Med., 2021, 10: 4843. doi: 10.3390/jcm10214843Cabezudo-GarcíaP.Ciano-PetersenN.L.Mena-VázquezN.Ortega-PinazoJ.Postigo-PozoM.J.García-MartínG.: Prevalence of Neural Autoantibodies in Paired Serum and Cerebrospinal Fluid in Adult Patients with -Resistant Temporal Lobe Epilepsy of Unknown Etiology. J. Clin. Med., 2021, 10: 4843. doi: 10.3390/jcm10214843Open DOISearch in Google Scholar
Cabezudo-García P., Mena-Vázquez N., Ciano-Petersen N.L., García-Martín G., Estivill-Torrús G., Serrano-Castro PJ.:Prevalence of Neural Autoantibodies in Epilepsy of Unknown Etiology: Systematic Review and Meta-Analysis. Brain Sci., 2021, 11: 392. doi: 10.3390/brainsci11030392Cabezudo-GarcíaP.Mena-VázquezN.Ciano-PetersenN.L.García-MartínG.Estivill-TorrúsG.Serrano-CastroPJ.: Prevalence of Neural Autoantibodies in Epilepsy of Unknown Etiology: Systematic Review and Meta-Analysis. Brain Sci., 2021, 11: 392. doi: 10.3390/brainsci11030392Open DOISearch in Google Scholar
Cabezudo-García P., Mena-Vázquez N., Villagrán-García M., Serrano-Castro PJ.:Efficacy of antiepileptic drugs in autoimmune epilepsy: A systematic review. Seizure, 2018, 59: 72–76. Doi: 10.1016/j.seizure.2018.05.004Cabezudo-GarcíaP.Mena-VázquezN.Villagrán-GarcíaM.Serrano-CastroPJ.: Efficacy of antiepileptic drugs in autoimmune epilepsy: A systematic review. Seizure, 2018, 59: 72–76. Doi: 10.1016/j.seizure.2018.05.004Open DOISearch in Google Scholar
Dalic L., Cook M.J.:Managing drug-resistant epilepsy: challenges and solutions. Neuropsychiatr Dis Treat, 2016, 12: 2605– 2616. doi: 10.2147/NDT.S84852DalicL.CookM.J.: Managing drug-resistant epilepsy: challenges and solutions. Neuropsychiatr Dis Treat, 2016, 12: 2605–2616. doi: 10.2147/NDT.S84852Open DOISearch in Google Scholar
Dubey D., Pittock S.J., McKeon A.:Antibody Prevalence in Epilepsy and Encephalopathy score: Increased specificity and applicability. Epilepsia, 2019, 60: 367–369. Doi: 10.1111/epi.14649DubeyD.PittockS.J.McKeonA.: Antibody Prevalence in Epilepsy and Encephalopathy score: Increased specificity and applicability. Epilepsia, 2019, 60: 367–369. Doi: 10.1111/epi.14649Open DOISearch in Google Scholar
Dubey D., Pittock S.J., Kelly C.R., McKeon A., Lopez-Chiriboga A.S., Lennon V.A. et al.:Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis. Ann Neurol, 2018, 83:166–177. Doi: 10.1002/ana.25131DubeyD.PittockS.J.KellyC.R.McKeonA.Lopez-ChiribogaA.S.LennonV.A.: Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis. Ann Neurol, 2018, 83:166–177. Doi: 10.1002/ana.25131Open DOISearch in Google Scholar
Dubey D., Singh J., Britton J.W., Pittock S.J., Flanagan E.P., Lennon V.A. et al.:Predictive models in the diagnosis and treatment of autoimmune epilepsy. Epilepsia, 2017, 58: 1181–1189. Doi: 10.1111/epi.13797DubeyD.SinghJ.BrittonJ.W.PittockS.J.FlanaganE.P.LennonV.A.: Predictive models in the diagnosis and treatment of autoimmune epilepsy. Epilepsia, 2017, 58: 1181–1189. Doi: 10.1111/epi.13797Open DOISearch in Google Scholar
Ekizoglu E., Baykan B., Sezgin M., Erdag E., Gundogdu-Un-verengil G., Vanli-Yavuz E.N. et al.:Follow-up of patients with epilepsy harboring antiglycine receptor antibodies. Epilepsy Behav, 2019, 92: 103–107. doi: 10.1016/j.yebeh.2018.09.034EkizogluE.BaykanB.SezginM.ErdagE.Gundogdu-Un-verengilG.Vanli-YavuzE.N.: Follow-up of patients with epilepsy harboring antiglycine receptor antibodies. Epilepsy Behav, 2019, 92: 103–107. doi: 10.1016/j.yebeh.2018.09.034Open DOISearch in Google Scholar
Feyissa A.M., López Chiriboga A.S., Britton J.W.:Antiepileptic drug therapy in patients with autoimmune epilepsy. Neurol Neuroimmunol Neuroinflamm, 2017, 4: 353. doi: 10.1212/NXI.0000000000000353FeyissaA.M.López ChiribogaA.S.BrittonJ.W.: Antiepileptic drug therapy in patients with autoimmune epilepsy. Neurol Neuroimmunol Neuroinflamm, 2017, 4: 353. doi: 10.1212/NXI.0000000000000353Open DOISearch in Google Scholar
Graus F., Titulaer M.J., Balu R., Benseler S., Bien C.G., Celluc-ci T. et al.:A clinical approach to the diagnosis of autoimmune encephalitis. Lancet Neurol, 2016, 15:391–404. doi: 10.1016/S1474-4422(15)00401-9GrausF.TitulaerM.J.BaluR.BenselerS.BienC.G.Celluc-ciT.: A clinical approach to the diagnosis of autoimmune encephalitis. Lancet Neurol, 2016, 15:391–404. doi: 10.1016/S1474-4422(15)00401-9Open DOISearch in Google Scholar
Hottenrott T., Dersch R., Berger B., Rauer S., Huzly D., Stich O.:The MRZ reaction in primary progressive multiple sclerosis. Fluids Barriers CNS, 2017, 14: 2. doi: 10.1186/s12987-016-0049-7HottenrottT.DerschR.BergerB.RauerS.HuzlyD.StichO.: The MRZ reaction in primary progressive multiple sclerosis. Fluids Barriers CNS, 2017, 14: 2. doi: 10.1186/s12987-016-0049-7Open DOISearch in Google Scholar
Jang Y., Kim D.W., Yang K.I., Byun J.I., Seo J.G., No Y. J. et al.:Drug Committee of Korean Epilepsy Society. Clinical Approach to Autoimmune Epilepsy. J. Clin. Neurol., 2020, 16: 519–529. Doi: 10.3988/jcn.2020.16.4.519JangY.KimD.W.YangK.I.ByunJ.I.SeoJ.G.NoY. J.: Drug Committee of Korean Epilepsy Society. Clinical Approach to Autoimmune Epilepsy. J. Clin. Neurol., 2020, 16: 519–529. Doi: 10.3988/jcn.2020.16.4.519Open DOISearch in Google Scholar
Kelley B.P., Patel S.C., Marin H.L., Corrigan J.J., Mitsias P.D., Griffith B.:Autoimmune encephalitis: Pathophysiology and imaging review of an overlooked diagnosis. Am. J. Neuroradiol, 2017, 38: 1070–1078. doi: 10.3174/ajnr.A5086KelleyB.P.PatelS.C.MarinH.L.CorriganJ.J.MitsiasP.D.GriffithB.: Autoimmune encephalitis: Pathophysiology and imaging review of an overlooked diagnosis. Am. J. Neuroradiol, 2017, 38: 1070–1078. doi: 10.3174/ajnr.A5086Open DOISearch in Google Scholar
Ong M.S., Kohane I.S., Cai T., Gorman M.P., Mandl K.D.:Population-level evidence for an autoimmune etiology of epilepsy. JAMA Neurol., 2014, 71: 569–74. doi: 10.1001/jaman-eurol.2014.188OngM.S.KohaneI.S.CaiT.GormanM.P.MandlK.D.: Population-level evidence for an autoimmune etiology of epilepsy. JAMA Neurol., 2014, 71: 569–74. doi: 10.1001/jaman-eurol.2014.188Open DOISearch in Google Scholar
Scheffer, I.E., Berkovic S., Capovilla G., Connolly M.B., French J., Guilhoto L. et al.:ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology. Epilepsia, 2017, 58: 512–521. Doi: 10.1111/epi.13709SchefferI.E.BerkovicS.CapovillaG.ConnollyM.B.FrenchJ.GuilhotoL.: ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology. Epilepsia, 2017, 58: 512–521. Doi: 10.1111/epi.13709Open DOISearch in Google Scholar
Sculier C., Gaínza-Lein M., Sánchez Fernández I., Lodden-kemper T.:Long-term outcomes of status epilepticus: A critical assessment. Epilepsia, 2018, 59: 155–169. Doi: 10.1111/epi.14515SculierC.Gaínza-LeinM.Sánchez FernándezI.Lodden-kemperT.: Long-term outcomes of status epilepticus: A critical assessment. Epilepsia, 2018, 59: 155–169. Doi: 10.1111/epi.14515Open DOISearch in Google Scholar
Steriade C., Britton J., Dale R.C., Gadoth A., Irani S.R., Linnoila J. et al.:Acute symptomatic seizures secondary to autoimmune encephalitis and autoimmune-associated epilepsy: Conceptual definitions. Epilepsia, 2020, 61: 1341–1351. Doi: 10.1111/epi.16571SteriadeC.BrittonJ.DaleR.C.GadothA.IraniS.R.LinnoilaJ.: Acute symptomatic seizures secondary to autoimmune encephalitis and autoimmune-associated epilepsy: Conceptual definitions. Epilepsia, 2020, 61: 1341–1351. Doi: 10.1111/epi.16571Open DOISearch in Google Scholar
Toledano M., Britton J.W., McKeon A., Shin C., Lennon V.A., Quek A.M.L. et al.:Utility of an immunotherapy trial in evaluating patients with presumed autoimmune epilepsy. Neurology, 2014, 82: 1578–1586. doi: 10.1212/WNL.0000000000000383ToledanoM.BrittonJ.W.McKeonA.ShinC.LennonV.A.QuekA.M.L.: Utility of an immunotherapy trial in evaluating patients with presumed autoimmune epilepsy. Neurology, 2014, 82: 1578–1586. doi: 10.1212/WNL.0000000000000383Open DOISearch in Google Scholar
Verbeek M.M., Notting E.A., Faas B., Claessens-Linskens R., Jongen P.J.:Increased cerebrospinal fluid chitotriosidase index in patients with multiple sclerosis. Acta Neurol. Scand., 2010, 121: 309–314. doi: 10.1111/j.1600-0404.2009.01242.xVerbeekM.M.NottingE.A.FaasB.Claessens-LinskensR.JongenP.J.: Increased cerebrospinal fluid chitotriosidase index in patients with multiple sclerosis. Acta Neurol. Scand., 2010, 121: 309–314. doi: 10.1111/j.1600-0404.2009.01242.xOpen DOISearch in Google Scholar
Vincent A.:Developments in autoimmune channelopathies. Autoimmun Rev., 2013, 12: 678–681. doi: 10.1016/j.autrev.2012.10.016VincentA.: Developments in autoimmune channelopathies. Autoimmun Rev., 2013, 12: 678–681. doi: 10.1016/j.autrev.2012.10.016Open DOISearch in Google Scholar
Vogrig A., Joubert B., André-Obadia N., Gigli G.L., Rheims S., Honnorat J.:Seizure specificities in patients with antibody-mediated autoimmune encephalitis. Epilepsia, 2019, 60: 1508– 1525. Doi: 10.1111/epi.16282VogrigA.JoubertB.André-ObadiaN.GigliG.L.RheimsS.HonnoratJ.: Seizure specificities in patients with antibody-mediated autoimmune encephalitis. Epilepsia, 2019, 60: 1508–1525. Doi: 10.1111/epi.16282Open DOISearch in Google Scholar
Walker L., Sills G.J.:Inflammation and Epilepsy: The Foundations for a New Therapeutic Approach in Epilepsy? Epilepsy Curr., 2012, 12: 8–12. doi: 10.5698/1535-7511-12.1.8WalkerL.SillsG.J.: Inflammation and Epilepsy: The Foundations for a New Therapeutic Approach in Epilepsy?Epilepsy Curr., 2012, 12: 8–12. doi: 10.5698/1535-7511-12.1.8Open DOISearch in Google Scholar
Yeshokumar A.K., Coughlin A., Fastman, J., Psaila K., Harmon M., Randell T. et al.:Seizures in autoimmune encephalitis – A systematic review and quantitative synthesis. Epilepsia, 2021, 62: 397–407. doi: 10.1111/epi.16807YeshokumarA.K.CoughlinA., Fastman, J., PsailaK.HarmonM.RandellT.: Seizures in autoimmune encephalitis – A systematic review and quantitative synthesis. Epilepsia, 2021, 62: 397–407. doi: 10.1111/epi.16807Open DOISearch in Google Scholar